Pages that link to "Q55098208"

The following pages link to Mariagrazia Catanoso (Q55098208):

Displaying 32 items.

• Gastro-intestinal permeability is increased in patients with limited systemic sclerosis (Q28182558) (← links)
• ANCA-associated vasculitis in childhood: recent advances. (Q33644574) (← links)
• Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. (Q34574567) (← links)
• Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study (Q36993376) (← links)
• Complex interplay between neutral and adaptive evolution shaped differential genomic background and disease susceptibility along the Italian peninsula (Q37223446) (← links)
• New indications for biological therapies. (Q37947157) (← links)
• Adalimumab in psoriatic arthritis (Q38023174) (← links)
• Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature (Q38083961) (← links)
• Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period (Q40740882) (← links)
• Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia (Q42632287) (← links)
• Multidisciplinary focus on cyclosporin A. (Q43297116) (← links)
• Lumbar interspinous bursitis in active polymyalgia rheumatica (Q44247613) (← links)
• Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. (Q44756545) (← links)
• Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study (Q45716430) (← links)
• Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. (Q46428522) (← links)
• Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. (Q50933050) (← links)
• Epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) in Northern Italy: a 15-year population-based study. (Q51077081) (← links)
• IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population. (Q51312648) (← links)
• Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study (Q51714523) (← links)
• Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study (Q51771728) (← links)
• Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial (Q57786353) (← links)
• PTPN22 R620W polymorphism in the ANCA-associated vasculitides (Q58885872) (← links)
• Interleukin-10 promoter polymorphisms in giant cell arteritis (Q79390785) (← links)
• Cervical interspinous bursitis in active polymyalgia rheumatica (Q80523086) (← links)
• -463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis (Q80807117) (← links)
• Tocilizumab: a novel therapy for patients with large-vessel vasculitis (Q82461505) (← links)
• Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis (Q85001806) (← links)
• Comparison between colour duplex sonography findings and different histological patterns of temporal artery (Q88634710) (← links)
• CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis (Q87355125) (← links)
• Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study (Q90280968) (← links)
• Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography (Q95541963) (← links)
• Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study (Q95644252) (← links)